利尿剂的临床药代动力学 - Suppr

Suppr

超能文献

Clinical pharmacokinetics of diuretics.

作者信息

Beermann B, Groschinsky-Grind M

出版信息

Clin Pharmacokinet. 1980 May-Jun;5(3):221-45. doi: 10.2165/00003088-198005030-00003.

DOI:10.2165/00003088-198005030-00003

PMID:6993083

Abstract

摘要

相似文献

Clinical pharmacokinetics of diuretics.利尿剂的临床药代动力学

Clin Pharmacokinet. 1980 May-Jun;5(3):221-45. doi: 10.2165/00003088-198005030-00003.

Pharmacokinetics of the thiazide diuretics.

Biopharm Drug Dispos. 1986 Nov-Dec;7(6):501-35. doi: 10.1002/bdd.2510070602.

Clinical pharmacology of diuretics.

Clin Exp Hypertens A. 1983;5(2):157-66. doi: 10.3109/10641968309048818.

[Alternatives to digitalis therapy: diuretics].

Verh Dtsch Ges Inn Med. 1977;83:148-54.

What are the metabolic complications of diuretic treatment?利尿剂治疗的代谢并发症有哪些？

Geriatrics. 1982 Feb;37(2):93-104.

[Diuretics].

Nihon Rinsho. 1995 Feb;53 Su Pt 1:960-5.

[Thiazide diuretics and nonthiazide diuretics].[噻嗪类利尿剂和非噻嗪类利尿剂]

Nihon Rinsho. 2000 Feb;58 Suppl 2:85-9.

Diuretics.

Nursing. 1983 Aug;13(8):suppl 1-2.

Current drug therapy - thiazide diuretics.当前药物治疗——噻嗪类利尿剂。

Am J Hosp Pharm. 1975 May;32(5):473-80.

Loop diuretics and thiazides--the case for their combination in chronic renal failure.袢利尿剂和噻嗪类利尿剂——它们联合用于慢性肾衰竭的情况

Nephrol Dial Transplant. 1996 Mar;11(3):408-10.

引用本文的文献

Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal.通过共结晶调整氯噻酮的水溶性：新型氯噻酮-咖啡因共晶体的稳定性和溶解行为

Pharmaceutics. 2022 Jan 30;14(2):334. doi: 10.3390/pharmaceutics14020334.

An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology.基于数据挖掘方法的药物吸收影响因素调查及食物效应预测

AAPS J. 2019 Dec 10;22(1):11. doi: 10.1208/s12248-019-0394-y.

[Spironolactone in dermatological treatment. On and off label indications].[螺内酯在皮肤科治疗中的应用。适应证的标注与未标注情况]

Hautarzt. 2013 Oct;64(10):762-7. doi: 10.1007/s00105-013-2597-y.

Aldosterone receptor antagonists: current perspectives and therapies.醛固酮受体拮抗剂：当前观点与治疗方法

Vasc Health Risk Manag. 2013;9:321-31. doi: 10.2147/VHRM.S33759. Epub 2013 Jun 24.

Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.青少年后女性寻常痤疮患者口服螺内酯：基于当前数据和临床经验的临床医生实用考量

J Clin Aesthet Dermatol. 2012 Mar;5(3):37-50.

Does Smoking Act as a Friend or Enemy of Blood Pressure? Let Release Pandora's Box.吸烟对血压是友是敌？让我们一探究竟。

Cardiol Res Pract. 2011 Jan 19;2011:264894. doi: 10.4061/2011/264894.

Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers.氢氯噻嗪在健康男性志愿者中的疗效以及ACE、ADD1和GNB3基因多态性

Eur J Clin Pharmacol. 2006 Mar;62(3):195-201. doi: 10.1007/s00228-005-0081-z. Epub 2006 Feb 1.

Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.健康受试者单次及重复使用利尿剂后的肾脏排泄反应：临床意义

Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:29-44. doi: 10.1007/BF00877956.

Loop diuretics versus others in the treatment of congestive heart failure after myocardial infarction.袢利尿剂与其他药物治疗心肌梗死后充血性心力衰竭的比较。

Cardiovasc Drugs Ther. 1993 Dec;7(6):869-76. doi: 10.1007/BF00877717.

Assessment of natriuretic drugs.利钠药物的评估。

Br J Clin Pharmacol. 1981 Oct;12(4):465-74. doi: 10.1111/j.1365-2125.1981.tb01252.x.

本文引用的文献

[STUDIES WITH THE SALURETIC 4-CHLORO-N-(2-FURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID. I].[对利钠素4-氯-N-(2-呋喃甲基)-5-氨磺酰基邻氨基苯甲酸的研究。I]

Arzneimittelforschung. 1964 Jun;14:709-10.

S35-LABELED BENDROFLUMETHIAZIDE IN HUMAN BEINGS: CLINICAL STUDIES.人体中S35标记的苄氟噻嗪：临床研究

Arch Intern Med. 1964 Mar;113:373-7. doi: 10.1001/archinte.1964.00280090059010.

The meetabolism of amiloride hydroloride in man.盐酸阿米洛利在人体内的代谢。

Clin Pharmacol Ther. 1969 May-Jun;10(3):401-6. doi: 10.1002/cpt1969103401.

Ototoxic side-effects of high doses of frusemide in patients with uraemia.

Postgrad Med J. 1971 Apr;47:Suppl:54-6.

Prediction of stability in pharmaceutical preparations. XVI. Kinetics of hydrolysis of canrenone and lactonization of canrenoic acid.药物制剂稳定性的预测。十六。坎利酮的水解动力学和坎利酸的内酯化反应

J Pharm Sci. 1971 Dec;60(12):1801-9. doi: 10.1002/jps.2600601206.

Pharmacokinetic and metabolic fate of potassium canrenoate (SC-14266) in man.安体舒通钾（SC - 14266）在人体中的药代动力学及代谢转归

J Pharm Sci. 1971 May;60(5):708-15. doi: 10.1002/jps.2600600510.

Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.螺内酯和坎利酸钾在心脏和肝脏衰竭中的多剂量动力学

Eur J Clin Pharmacol. 1974;7(3):195-200. doi: 10.1007/BF00560381.

Improved method for estimating chlorthalidone in body fluids.

J Pharm Sci. 1974 Jul;63(7):1065-8. doi: 10.1002/jps.2600630706.

Pharmacokinetics of furosemide in normal subjects and functionally anephric patients.速尿在正常受试者和功能性无肾患者中的药代动力学。

Clin Pharmacol Ther. 1974 Jun;15(6):588-96. doi: 10.1002/cpt1974156588.

Application of the extractive alkylation technique to the gas chromatographic determination of chlorthalidone in plasma in nanogram quantities.

Anal Chem. 1974 Jan;46(1):39-42. doi: 10.1021/ac60337a046.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验